Efficacy and Safety of LXI-15028 Comparing With Esomeprazole in the Treatment of Erosive Esophagitis
Clinical trial NCT03615677 · COMPLETED
Trial details
- NCT number
- NCT03615677
- Sponsor
- Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-24
- Primary completion
- 2019-10-18
- Enrollment
- 261
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.